Tech Company Financing Transactions
gel-e Funding Round
On 7/15/2017, gel-e announced $3.1 million in funding from National Science Foundation and TEDCO.
Transaction Overview
Company Name
Announced On
7/15/2017
Transaction Type
Venture Equity
Amount
$3,100,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand its initial U.S. FDA regulatory clearance for the management of bleeding wounds, including vascular access sites (Vascular gel-e) to a broader hemostatic product line for the treatment of external wounds and to establish cGMP manufacturing of active ingredient.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
387 Technology Dr.
College Park, MD 20742
USA
College Park, MD 20742
USA
Phone
Website
Email Address
Overview
gel-e has the potential to be a disruptive innovation in the manangement of human bleeding. But don't take our word for it, watch the video to your right, where gel-e is featured as a Top Innovator in Stephen Hawking's BBC series.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Rich Vincent
Chief Scientific Officer
Matthew Dowling
President
Larry Tiffany
VP - Manufacturing
Bruce Choi
VP - Regulatory Affairs
Elsa Abruzzo
Browse more venture capital transactions:
Prev: 7/15/2017: Impartner venture capital transaction
Next: 7/15/2017: Assent Compliance venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs